Recent research conducted in Australia shows that many oncologists withhold information about expensive unfunded drugs in what the authors of the study suggest is unacceptable medical paternalism. Surprised by the Australian results, we ran a version of the study in New Zealand and received very different results. While the percentages of clinicians who would prescribe the drugs described in the scenarios were very similar (73–99% in New Zealand and 72–94% in Australia depending on the scenario) the percentage who would not discuss expensive unfunded drugs was substantially lower in New Zealand (6.4–11.1%) than it was in Australia (28–41%). This seems surprising given the substantial similarities between the two countries, and the extensive interaction between their medical professions. We use the contrast between the two studies to examine the generalisability of the Australian results, to identify influences on clinicians' decisions about what treatment information to give patients, and so the tendency towards medical paternalism and, more pragmatically, about how such decisions might be influenced.
- medical ethics
- expensive treatments
- treatment information
- patient autonomy
Statistics from Altmetric.com
Funding University of Auckland Philosophy research funds.
Competing interests None.
Ethics approval This study was conducted with the approval of the University of Auckland Human Participants Ethics Committee (August 13, 2008, Ref. 2008/Q/039).
Provenance and peer review Not commissioned; externally peer reviewed.